PT SERVIER INDONESIA

PT Servier Indonesia Company Profile

PT Servier Indonesia is the Indonesian subsidiary of Servier, a leading global independent pharmaceutical group headquartered in France. The company is dedicated to therapeutic innovation to serve patient needs worldwide. In Indonesia, PT Servier Indonesia focuses on the marketing, sales, and distribution of a diverse portfolio of prescription pharmaceutical products. These products span various therapeutic areas, including cardiovascular diseases, diabetes, oncology, and central nervous system disorders. The company's mission aligns with Servier's global commitment to research and development of new medicines and ensuring their accessibility to patients, contributing significantly to the Indonesian healthcare landscape by providing innovative and essential treatments.

Factory or Trader

PT Servier Indonesia primarily operates as a trader and distributor of pharmaceutical products. It imports finished pharmaceutical products manufactured by Servier's global facilities and is responsible for their marketing, sales, and distribution across Indonesia. While local operations may include secondary packaging, labeling, and quality control, its core business in Indonesia is not the full-scale manufacturing (factory) of pharmaceutical compounds or dosage forms from raw materials.

PT SERVIER INDONESIA Products:

* Daflon (Diosmin and Hesperidin)

* Coversyl/Preterax (Perindopril Arginine)

* Diamicron MR (Gliclazide)

* Protelos/Osseor (Strontium Ranelate)

* Valdoxan/Thymanax (Melatonin)